Legal Representation
Attorney
Charles Y. Park
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 6, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 6, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 6, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Mar 11, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 11, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 11, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 11, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 11, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 11, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 19, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 27, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 27, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 24, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 23, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 18, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 17, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Sep 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 12, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical agents affecting peripheral nervous system; dietary fiber to aid digestion; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular pharmaceutical preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; eye drops; allergy medications; dietetic food substances, namely, plant-derived bioactive compounds, mitochondria-targeted supplements, and functional nutraceuticals for cardiovascular, immune, and metabolic health adapted for medical use; bath preparations for medical purposes; diagnostic agents for medical use; slimming tea for medical purposes; pharmaceutical compositions for the prevention and treatment of mitochondrial disorders, metabolic imbalances, cardiovascular diseases, immune dysregulation, cancer, fibrosis, and neurodegenerative diseases; pharmaceutical preparations for enhancing mitochondrial bioenergetics to support cardiovascular function, regulate immune responses, prevent and treat cardiac fibrosis, and improve vascular and metabolic health; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis of mitochondrial disorders, cardiovascular diseases, immune dysregulation, cancer progression, neurodegenerative progression, and metabolic imbalances; analgesic balm; nutraceuticals for therapeutic purposes in the nature of mitochondrial energy restoration, immune system modulation, endothelial function support, and fibrosis attenuation; nutraceutical preparations for therapeutic and medical purposes in the nature of cardiovascular protection, oxidative stress regulation, immune system enhancement, and cellular metabolism optimization; pharmaceutical preparations for the treatment of parkinson's disease; antimicrobials for dermatologic use; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparation for skin care; pharmaceutical preparations for skin care; antihypertensives; anti-diabetic pharmaceuticals; anti-cancer preparations; anti-sarcoma preparations; anticoagulants; anti-cancer preparations in the nature of antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; pharmaceutical preparations for the prevention of disorders of the respiratory system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory organs; pharmaceutical preparations in the nature of pharmaceutical compounds for treating respiratory diseases and infections; pharmaceutical products for treating respiratory diseases; inhaled pharmaceutical preparations for the treatment of respiratory diseases and infections; pharmaceutical preparations for treating respiratory diseases and infections.
Class 042
Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; Research and development of medicines.
Classification
International Classes
005
042